Showing results (51-60 of 156) with videos related to
Sort By:
Pageof 16
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 26, 2010
Anticholinergic effects of cis- and trans-isomers of two metabolites of propiverineStefan Propping, Manfred Braeter, Marc-Oliver Grimm, et al.International Urology and Nephrology|April 23, 2014
FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancersTorsten Gruschwitz, Mieczyslaw Gajda, Astrid Enkelmann, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 6, 2018
Prostate Artery Embolization: Indication, Technique and Clinical ResultsUlf Teichgräber, René Aschenbach, Ioannis Diamantis, et al.The Prostate|February 11, 2011
Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia?Susan Voigt, Friederike Hüttig, Rainer Koch, et al.Urologia Internationalis|January 22, 2008
Clinical and functional results after continent cutaneous urinary diversion with the ileal double-T-pouchHans-Helge Seifert, Alice Obaje, Volker Müller-Mattheis, et al.Oncogene|December 8, 2004
KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cellsAlexandra Marreiros, Kip Dudgeon, Vinh Dao, et al.Scandinavian Journal of Urology and Nephrology|June 19, 2004
Penile metastasis secondary to follicular thyroid carcinomaMarc-Oliver Grimm, Philipp Spiegelhalder, Hansjörg Heep, et al.Acta Radiologica (Stockholm, Sweden : 1987)|May 1, 2010
Whole-body MRI in follow-up of patients with renal cell carcinomaIvan Platzek, Stefan Zastrow, Pierre-Emanuel Deppe, et al.Urologic Oncology|December 12, 2002
Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell linesPaul Jackson, Marc-Oliver Grimm, Elizabeth A Kingsley, et al.Plos One|April 22, 2025
Correction: Optimal length and temporal resolution of dynamic contrast-enhanced MR imaging for the differentiation between prostate cancer and normal peripheral zone tissueMarius Hellstern, Carlos Martinez, Christopher Wallenhorst, et al.Pageof 16